Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Research Tools and Instruments

McMaster University

$150,000.00

Advanced Photopolymerization 3D Bioprinters to Produce Tissue Mimetics

FY 2024-25

Summary
3D printing is revolutionizing the way products are manufactured, with benefits including higher customization, expedited prototyping, and lower costs. Biofabrication is expanding, with the number of reports on 3D printed microenvironments and companies dedicated to commercializing 3D printing materials for tissue engineering growing rapidly. This proposal seeks funding for extrusion and volumetric 3D bioprinters capable of photo-polymerization of hydrogel, nanomaterial, and cell-laden bioinks into 3D scaffolds for cell culture and tissue biomimetics. The requested 3D bioprinters are urgently needed by the Moran-Mirabal and Hirota groups to advance work on novel bioinks that enable 3D printing high-fidelity constructs containing extra cellular matrix proteins, nanomaterials, and cells. These living constructs are being used to establish advanced lung tissue models for the study of lung biology in the context of development, ageing, and innate immunity. The Moran-Mirabal lab currently owns an extrusion 3D bioprinter, which is used daily to test new bioink formulations and build tissue biomimetic models. Unfortunately, the manufacturer exited the bioprinting market and ceased to support repairs for this bioprinter, leaving our groups with no available options for extrusion 3D bioprinting. In addition, there are no volumetric photo-polymerization 3D printers available at McMaster. Lack of access to these two key instruments would severely limit our ability to continue to develop bioinks, print 3D constructs and answer basic biological questions, file IP for new tissue biomimetics, and publish our research - ultimately hindering trainee progression. The requested 3D bioprinters will be located in the Moran-Mirabal lab and the Centre for Advanced Light Microscopy at McMaster. They will be set up in Containment Level 2 lab,s equipped with instrumentation for cell culture, and accessible to PIs from the Faculties of Science, Engineering and Health Sciences. The instruments will be operated as shared platforms available to groups interested in bioprinting 3D scaffolds for biomedical applications, with priority access for the applicants. The availability of such 3D bioprinters will also enhance the research programs of other groups who are not eligible to participate as co-applicants, including the Adronov, Grandfield, Hoare, Kolb, Parise, Sheardown, Wylie, and Zhang groups, by allowing them to test new materials for 3D printing or evaluate the response of cells to 3D printed scaffolds (e.g., osteoblast for bone regeneration on implants). A delay in securing the requested 3D printers would not only prevent the applicants' research groups from expeditiously moving forward research on new 3D printing bioinks but would also prevent them from 3D printing tissue biomimetics to investigate fundamental biological questions, their ability to apply for patents, publish their results, and move student research to its full potential.
Program
Research Tools and Instruments
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RTI-2025-00370
Name nom
Moran-Mirabal, Jose
Department département
Chemistry and Chemical Biology
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2025
Award amount
150000
Program id
RTI
Program name en
Research Tools and Instruments
Program name fr
Outils et instruments de recherche
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1611
Committee name en
Materials and Chemical Engineering (RTI)
Committee name fr
Génie chimique et des matériaux (OIR)
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Advanced Photopolymerization 3D Bioprinters to Produce Tissue Mimetics
Keywords
3d bioprinting; cell microenvironments; 3d scaffolds; bioinks; viscoelastic materials; volumetric 3d printing; tissue engineering; hydrogels; biomimetics; additive manufacturing
Application summary
3D printing is revolutionizing the way products are manufactured, with benefits including higher customization, expedited prototyping, and lower costs. Biofabrication is expanding, with the number of reports on 3D printed microenvironments and companies dedicated to commercializing 3D printing materials for tissue engineering growing rapidly. This proposal seeks funding for extrusion and volumetric 3D bioprinters capable of photo-polymerization of hydrogel, nanomaterial, and cell-laden bioinks into 3D scaffolds for cell culture and tissue biomimetics. The requested 3D bioprinters are urgently needed by the Moran-Mirabal and Hirota groups to advance work on novel bioinks that enable 3D printing high-fidelity constructs containing extra cellular matrix proteins, nanomaterials, and cells. These living constructs are being used to establish advanced lung tissue models for the study of lung biology in the context of development, ageing, and innate immunity. The Moran-Mirabal lab currently owns an extrusion 3D bioprinter, which is used daily to test new bioink formulations and build tissue biomimetic models. Unfortunately, the manufacturer exited the bioprinting market and ceased to support repairs for this bioprinter, leaving our groups with no available options for extrusion 3D bioprinting. In addition, there are no volumetric photo-polymerization 3D printers available at McMaster. Lack of access to these two key instruments would severely limit our ability to continue to develop bioinks, print 3D constructs and answer basic biological questions, file IP for new tissue biomimetics, and publish our research - ultimately hindering trainee progression. The requested 3D bioprinters will be located in the Moran-Mirabal lab and the Centre for Advanced Light Microscopy at McMaster. They will be set up in Containment Level 2 lab,s equipped with instrumentation for cell culture, and accessible to PIs from the Faculties of Science, Engineering and Health Sciences. The instruments will be operated as shared platforms available to groups interested in bioprinting 3D scaffolds for biomedical applications, with priority access for the applicants. The availability of such 3D bioprinters will also enhance the research programs of other groups who are not eligible to participate as co-applicants, including the Adronov, Grandfield, Hoare, Kolb, Parise, Sheardown, Wylie, and Zhang groups, by allowing them to test new materials for 3D printing or evaluate the response of cells to 3D printed scaffolds (e.g., osteoblast for bone regeneration on implants). A delay in securing the requested 3D printers would not only prevent the applicants' research groups from expeditiously moving forward research on new 3D printing bioinks but would also prevent them from 3D printing tissue biomimetics to investigate fundamental biological questions, their ability to apply for patents, publish their results, and move student research to its full potential.
McMaster University - $150,000 Grant (2024-25) | Canada Spends